As of 2025-07-20, the Relative Valuation of Acacia Pharma Group PLC (ACPH.BR) is (11.42) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.89 EUR, the upside of Acacia Pharma Group PLC based on Relative Valuation is -1386.6%.
The range of the Relative Valuation is (11.79) - (12.43) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 14.4x | 11.6x |
| Forward P/E multiples | 13.6x - 15.4x | 14.8x |
| Fair Price | (11.79) - (12.43) | (11.42) |
| Upside | -1427.5% - -1499.6% | -1386.6% |
| Date | P/E |